These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31119318)

  • 1. Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma.
    Kesarwani P; Prabhu A; Kant S; Chinnaiyan P
    Cancer Immunol Immunother; 2019 Jul; 68(7):1107-1120. PubMed ID: 31119318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.
    Prabhu AH; Kant S; Kesarwani P; Ahmed K; Forsyth P; Nakano I; Chinnaiyan P
    Neuro Oncol; 2019 Feb; 21(3):337-347. PubMed ID: 30476237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
    Yan J; Kong LY; Hu J; Gabrusiewicz K; Dibra D; Xia X; Heimberger AB; Li S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan Metabolism Contributes to Radiation-Induced Immune Checkpoint Reactivation in Glioblastoma.
    Kesarwani P; Prabhu A; Kant S; Kumar P; Graham SF; Buelow KL; Wilson GD; Miller CR; Chinnaiyan P
    Clin Cancer Res; 2018 Aug; 24(15):3632-3643. PubMed ID: 29691296
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors.
    Wainwright DA; Sengupta S; Han Y; Lesniak MS
    Neuro Oncol; 2011 Dec; 13(12):1308-23. PubMed ID: 21908444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types.
    Khalsa JK; Cheng N; Keegan J; Chaudry A; Driver J; Bi WL; Lederer J; Shah K
    Nat Commun; 2020 Aug; 11(1):3912. PubMed ID: 32764562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
    Liu Y; Song C; Shen F; Zhang J; Song SW
    PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay between metabolic remodeling and immune regulation in glioblastoma.
    Kesarwani P; Kant S; Prabhu A; Chinnaiyan P
    Neuro Oncol; 2017 Oct; 19(10):1308-1315. PubMed ID: 28541512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma.
    Mohapatra SR; Sadik A; Tykocinski LO; Dietze J; Poschet G; Heiland I; Opitz CA
    Front Immunol; 2019; 10():2762. PubMed ID: 31866995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.
    Mieczkowski J; Kocyk M; Nauman P; Gabrusiewicz K; Sielska M; Przanowski P; Maleszewska M; Rajan WD; Pszczolkowska D; Tykocki T; Grajkowska W; Kotulska K; Roszkowski M; Kostkiewicz B; Kaminska B
    Oncotarget; 2015 Oct; 6(32):33077-90. PubMed ID: 26427514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis.
    Cui X; Morales RT; Qian W; Wang H; Gagner JP; Dolgalev I; Placantonakis D; Zagzag D; Cimmino L; Snuderl M; Lam RHW; Chen W
    Biomaterials; 2018 Apr; 161():164-178. PubMed ID: 29421553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment.
    Kant S; Kesarwani P; Prabhu A; Graham SF; Buelow KL; Nakano I; Chinnaiyan P
    Cell Death Dis; 2020 Apr; 11(4):253. PubMed ID: 32312953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
    Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
    Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma.
    De Leo A; Ugolini A; Yu X; Scirocchi F; Scocozza D; Peixoto B; Pace A; D'Angelo L; Liu JKC; Etame AB; Rughetti A; Nuti M; Santoro A; Vogelbaum MA; Conejo-Garcia JR; Rodriguez PC; Veglia F
    Immunity; 2024 May; 57(5):1105-1123.e8. PubMed ID: 38703775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.
    Authier A; Farrand KJ; Broadley KW; Ancelet LR; Hunn MK; Stone S; McConnell MJ; Hermans IF
    Int J Cancer; 2015 Jun; 136(11):2566-78. PubMed ID: 25363661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hijacking Sexual Immuno-Privilege in GBM-An Immuno-Evasion Strategy.
    Sharpe MA; Baskin DS; Jenson AV; Baskin AM
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
    Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
    Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
    Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
    Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study.
    Ali S; Borin TF; Piranlioglu R; Ara R; Lebedyeva I; Angara K; Achyut BR; Arbab AS; Rashid MH
    PLoS One; 2021; 16(2):e0246646. PubMed ID: 33544755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.